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Abstract: The plant A/B toxin ricin represents a heterodimeric glycoprotein belonging to the 
family of ribosome inactivating proteins, RIPs. Its toxicity towards eukaryotic cells results 
from the depurination of 28S rRNA due to the N-glycosidic activity of ricin toxin A chain, 
RTA. Since the extention of RTA by a mammalian-specific endoplasmic reticulum (ER) 
retention signal (KDEL) significantly increases RTA in vivo toxicity against mammalian 
cells,  we  here  analyzed  the  phenotypic  effect  of  RTA  carrying  the  yeast-specific  ER 
retention motif HDEL. Interestingly, such a toxin (RTA
HDEL) showed a similar cytotoxic 
effect  on  yeast  as  a  corresponding  RTA
KDEL  variant  on  HeLa  cells.  Furthermore,  we 
established a powerful yeast bioassay for RTA in vivo uptake and trafficking which is 
based on the measurement of dissolved oxygen in toxin-treated spheroplast cultures of 
S. cerevisiae. We show that yeast spheroplasts are highly sensitive against external applied 
RTA  and  further  demonstrate  that  its  toxicity  is  greatly  enhanced  by  replacing  the  
C-terminal KDEL motif by HDEL. Based on the RTA resistant phenotype seen in yeast 
knock-out  mutants  defective  in  early  steps  of  endocytosis  (∆end3)  and/or  in  RTA 
depurination  activity  on  28S  rRNA  (∆rpl12B)  we  feel  that  the  yeast-based  bioassay 
described in this study is a powerful tool to dissect intracellular A/B toxin transport from 
the plasma membrane through the endosomal compartment to the ER. 
Keywords: ricin toxin A chain; ER retention signal; yeast spheroplasts; toxin endocytosis 
and transport; oyxgen-sensor microtiter plate; H/KDEL 
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Abbreviations: ER, endoplasmic reticulum; RTA, ricin toxin A chain; RTB, ricin toxin B 
chain; PI, propidiumiodide 
 
1. Introduction 
The development of effective protecting drugs and antidotes against various human diseases and 
biological toxins is still a major goal in ongoing biomedical research. The plant Ricinus communis 
produces a heterodimeric protein toxin (ricin) which represents one of the most powerful A/B toxins of 
biological heritage [1]. The mature holotoxin represents a glycosylated heterodimer consisting of two 
polypeptide  chains  which are covalently linked  through  a single disulfide bond  [2,3]. Ricin toxin  
A-chain (RTA; 30 kDa) acts as N-glycosidase by cleaving a specific adenine residue at position 4324 
within the sarcin/ricin loop of 28S rRNA [4,5]. Loss of this adenine residue hesitates in vivo binding of 
elongation  factor  2  (EF2)  which  is  required  to  initiate  protein  translation  on  the  eukaryotic  80S  
ribosome [6]. Thus, ricin treated cells are rapidly blocked in protein biosynthesis and subsequently 
committed to cell death [2]. In contrast to RTA, the 34 kDa B-chain RTB represents the cell surface 
binding component which mediates toxin uptake by the target cell [7]. After toxin binding to terminal 
galactose and/or N-acetylglucosamine residues on the surface of mammalian cells, the toxin is taken up 
by  endocytosis  and  transported  to  early  endosomes  [7,8].  While  this  transport  can  occur  both  in  a  
clathrin-dependent or clathrin-independent manner [9–11], only 5% of the toxin molecules finally reach 
the TGN network [12]. Synthaxin 5 plays an important role in this toxin transport step [13]. In contrast 
to other A/B toxin family members such as Cholera toxin or the E. coli heat labile toxin HLT [14], ricin 
itself does not contain an ER retention signal which could potentially mediate its retrograde transport 
into the ER through binding to KDEL receptors of the mammalian target cell [15]. Therefore, it has 
been proposed that RTB binds to resident luminal ER proteins and is then transported piggyback into 
the ER [2]. After recognition by Edem1, ricin is presumably retrotranslocated into the cytosol, most 
likely by using the Sec61 translocon of the ER membrane [16–18]. After ER exit, a limited number of 
RTA molecules are somehow capable of escaping proteasomal degradation reaching their final target 
and causing cell death [16,19]. 
Despite our detailed knowledge on RTA in vivo toxicity, comparatively little is known about the 
intracellular toxin transport and the cellular components involved in this process. A deeper mechanistic 
understanding  of  toxin  trafficking  could  not  only  help  to  design  more  effective  antidotes  and 
immunotoxins, it would also foster development of novel therapeutic strategies for the treatment of 
various human diseases including cancer [20–22].  
The focus of our present study was to develop a yeast-based bioassay which would allow in vivo 
analyses of toxin uptake and transport in more detail. Previous studies already demonstrated that yeast 
ribosomes are highly sensitive to, and depurinated by, RTA [23]; however, so far all these studies have 
been performed by artificial RTA expression in the ER lumen. Therefore, analysis of intracellular 
toxin transport has largely been restricted to the analysis of toxin retrotranslocation from the ER into 
the cytosol [24]. Based on the observation that the addition of the mammalian-specific ER retention 
signal KDEL increases in vivo toxicity of ricin up to 250 fold [25,26], we asked if the addition of a 
yeast-specific ER retention signal (HDEL) to RTA likewise exhibits in vivo toxicity against HeLa Toxins 2011, 3                         
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cells. As we observed similar cytotoxicity for both toxin variants, RTA
HDEL and RTA
KDEl, we built-up 
a yeast-based bioassay for the analysis of RTA uptake and intracellular transport. Further studies with 
this novel test system should shed more light on ricin trafficking in vivo, thereby helping to identify host 
cell proteins that are mechanistically involved in the intoxification by microbial and plant A/B toxins. 
2. Materials and Methods 
2.1. Escherichia Coli Strains, Plasmids, Culture Media and Genetic Techniques 
Standard molecular manipulations were performed as described by [27]. E. coli TOP10 (F’mcrA Δ 
(mrr-hsdRMS-mcrBC) ʦ80lacZΔM15 ΔlacX74 recA1 araD139 Δ (ara-leu) 7697 galU galK rpsL (StrR) 
endA1 nupG) was used for cloning. Using pRS316-RTA as template, RTA(His)6, RTA(His)6HDEL and 
RTA(His)6KDEL were PCR amplified in the presence of HiFi polymerase (Roche) and the following 
primer pairs: 5'-RTA (5'-GGATCCATGATAATTCCCAAACAATACCCAATTATAAACTTTAC) and 
3'-RTA(His)6  (3'-AAGCTTGTCGACTTAATGATGATGATGATGATGAAACTGTGACGATGGTGGA 
GGTGC)  for  RTA(His)6,  5'-RTA  and  3'-RTA(His)6HDEL  (3'-AAGCTTGTCGACTTACAGTTCA 
TCATGATGATGATGATGATGATGAAACTGTGACGATGGTGGAGGTGC) for RTA(His)6HDEL, 
and  5'-RTA  and  3-RTA(His)6KDEL  (3'-AAGCTTGTCGACTTACAGTTCATCTTTATGATGAT 
GATGATGATGAAACTGTGACGATGGTGGAGGTGC) for RTA(His)6KDEL. Each primer introduced 
either a 5' BamHI or 3' HindIII/SalI cleavage site (underlined). After amplification, the corresponding 
DNA fragment was cloned into pSTBlue-1 (Novagen), sequenced and finally cloned as BamHI/HindIII 
fragment into pET24a
(+) (Novagen) to obtain the expression vectors pET-RTA, pET-RTAHDEL and 
pET-RTAKDEL, respectively. All constructs were subsequently transformed into E. coli BL21 (DE3) 
(F
− ompT gal dcm lon hsdSB (rB
− mB
−) λ (DE3 [lacI lacUV5–T7 gene 1 ind1 sam7 nin5], Stratagene) and 
after cells had reached an optimal density (OD600 ≈ 0.8–1), expression of each RTA variant was induced 
in the presence of 1 mM IPTG for 2 h at 28 ° C. Cells were harvested, washed twice with sterile water 
and  resuspended  in  binding  buffer  (500  mM  NaCl,  10  mM  imidazol  and  20 mM  KH2PO4)  for 
subsequent RTA purification. Cell debris was removed and the supernatant was collected for Ni
2+-NTA 
affinity  chromatography.  Sonicated  supernatants  were  immediately  used  for  SDS–PAGE,  western 
analysis and/or Coomassie blue staining. 
2.2. Yeast Strains and Culture Media 
The  S.  cerevisiae  wild-type  strain  BY4742  (MATʱ  his3Δ1,  leu2Δ0,  lys2Δ0,  ura3Δ0)  and  its 
isogenic knock-out mutants YNL084C (∆end3) and YDR418W (∆rpl12B) were obtained from Open 
Biosystems. Yeast cells were grown in YEPD (2% glucose, 2% peptone and 1% yeast extract) at  
30  ° C.  For  spheroplast  preparation,  each  strain  was  grown  in  YEPD  to  late  exponential  phase  
(4–6 ×  10
7 cells per mL), harvested at 8000 rpm and washed twice with sterile water. Subsequently,  
1 ×  10
9 cells were resuspended in 100 mL heroplast buffer (0.8 M sorbitol, 10 mM Tris-HCl (pH 7.5), 
10 mM CaCl2, 2 mM DTT and 200 µg/mL zymolyase 20 T), incubated at 30 ° C for 75 min, harvested 
at  4  ° C  and  2000 rpm  and  washed  twice  with  incubation  buffer  (0.8  M  sorbitol,  10  mM  
Tris-HCl (pH 4.7), 10 mM CaCl2, 10 mM glucose). Toxins 2011, 3                         
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2.3. Affinity Purification of RTA 
Sonicated supernatants of E. coli clones expressing the (His)6-tagged RTA variants were applied 
onto  a 5 mL HisTrap FF column (GE Healthcare) and eluted in  a single step by the addition  of 
imidazol (500 mM imidazol, 500 mM NaCl, 20 mM KH2PO4). Eluted protein fractions were desalted 
and equilibrated either in PBS (pH 7.4) for studies on mammalian cells or in incubation buffer for 
yeast experiments. Ni
2+-NTA purified supernatants of E. coli expressing the empty vector pET24a
(+) 
without RTA served as negative control. After concentration through 10 kDa cut-off spin columns 
(Sartorius, Viva Spin 20), purified proteins were stored at 4 ° C. Coomassie staining was employed to 
analyze protein purity and the level of protein expression was verified by western blot analysis. Total 
protein content was determined by using a BCA protein assay kit (Pierce). 
2.4. Western Analysis and Protein Staining 
After RTA  expression,  E. coli  supernatants  and Ni
2+-NTA purified fractions  were  analyzed by  
SDS-PAGE by separating protein samples in 15% Tris-tricine SDS polyacrylamide gels [28]. After 
electrotransfer to PVDF membranes, blots were incubated with a polyclonal antibody against the ricin 
A  subunit  (diluted  1/1000).  Thereafter,  blots  were  treated  with  monoclonal  peroxidase-coupled  
anti-sheep  antibody  (Sigma,  diluted  1/13,000)  and  developed  with  Western  lightning  Plus  ECL 
(PerkinElmer). Signals were detected with ChemiDoc XRS (BioRad). For Coomassie blue staining, 
SDS gels were incubated in a staining solution (0.1% (w/v) Coomassie blue R, 30% (v/v) methanol 
and 10% (v/v) acetic acid) for 2 h and thereafter destained in a solution containing 30% (v/v) methanol 
and 10% (v/v) acetic acid [29]. 
2.5. Phase Contrast Microscopy 
HeLa S3 cells were seeded in 24 well plates at a density of 1 ×  10
5 cells per well in DMEM medium 
containing 10% FCS and 1% penicillin-streptomycin and incubated at 37 ° C in the presence of 5% 
CO2 for 18 h. After an additional incubation in the presence of purified RTA and/or control samples 
for 24 or 48 h, phase contrast microscopy was performed using an Olympus IX70 microscope under 
standard settings. For trypan blue staining, DMEM medium was removed, cells were stained in 0.4% 
trypan blue (Sigma) for 5 min, washed with PBS and analyzed under the microscope and counted in an 
automated  cell  counter  (Invitrogen).  For  counting,  cells  were  harvested  24  or  48  h  after  RTA 
treatment.  Sample  supernatants  were  collected,  adherent  growing  cells  trypsinated  and  pooled. 
Subsequently, pooled supernatants were harvested at 2000 rpm, washed once with PBS, resuspended 
in  100  µL  PBS,  and  100  µL  0.4%  Trypan  Blue  were  added.  Cells  were  counted  after  3  min  
of incubation. 
2.6. Oyxgen-Sensor Microtiter Plate Bioassay 
Wild-type yeast cells and selected knock-out mutants were grown in YEPD to exponential phase and 
spheroplasted by treatment with zymolyase 20 T as described above. Yeast spheroplasts (1.5 ×  10
7 cells) 
were  seeded  into  96  well  oyxgen-sensor  microtiter  plates  (Presence,  round  bottoms).  Various 
concentrations of RTA variants were adjusted to a final volume of 200 µ L incubation buffer per well. Toxins 2011, 3                         
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In each measurement, a two point calibration was conducted. The k100 value was measured with air 
saturated water and the k0 value with water containing 0.1% Na2SO3 solution. Oyxgen concentration 
was measured every 20 min over a time window of 16 h. Each sample measurement was performed in 
triplicate at 30 ° C, 120 rpm and with a shaking diameter of 1 mm. Measurements were carried out in a 
fluorescence  reader  equipped  with  an  integrated  shaker  (Fluoroskan  Ascent,  Labsystems,  Vantaa, 
Finland) [30]. Oyxgen concentration and pO2 values were calculated according to the equations shown 
in (1) and (2). 
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2.7. Cytotoxicity Assay 
Yeast wild-type cells and knock-out mutants were cultivated and spheroplasted as described above. 
At a density of 1.5 ×  10
7 cells, intact cells and/or spheroplasts were incubated in black 96 well plates 
(Nunc) in the presence of each RTA variant in incubation buffer at 30 ° C and low shaking (115 rpm) 
for  24  h.  Measurements  were  performed  using  a  PARADIGM  (Beckham  Coulther,  Cartridge 
Multimode). Subsequently, cells were treated with 2.5 µL propidium iodide (PI, 1 mg/mL) for 3 min 
and  fluorescence  was  measured  at  an  extinction  wavelength  of  535  ±   25  nm  and  an  emission 
wavelength of 635 ±  25 nm for 140 ms. Fluorescence was expressed as shown in (3). 
    blank l heatcontro blank sample Absorption Absorption Absorption Absorption ce Fluorescen    / (3)     blank l heatcontro blank sample Absorption Absorption Absorption Absorption ce Fluorescen    / (3)   (3) 
All experiments and measurements were repeated five times (n = 5) and the corresponding standard 
deviations are indicated for each experiment. 
2.8. Cell Culture 
HeLa S3 cells were obtained from ATCC and maintained in DMEM medium supplemented with 10% 
FCS and 1% penicillin-streptomycin. For cell vitality assays (TOX2, XTT based, Sigma), HeLa cells 
were seeded in 24 well plates at a density of 1 ×  10
5 cells per well and incubated in DMEM medium at 
37 ° C in the presence of 5% CO2 for 18 h. Thereafter, HeLa cells were incubated in the presence of 
increasing concentrations of purified RTA in DMEM medium for another 24 or 48 h. Subsequently, 
cells were washed twice with PBS, centrifuged between each step at 1600 rpm and finally resuspended 
in DMEM without phenol red and FCS. Thereafter, XTT was added in a ratio of 20% of DMEM 
medium and cells were incubated at 37 ° C for another 3 h. Absorbance of the samples was measured 
with a spectrophotometer Ultrospec 2100 pro (Amershan Biosciences) at a wavelength of 450 nm. 
Cytotoxicity was expressed as shown in (4). 
(4)     blank control blank sample OD OD OD OD ty Cytotoxici    / (4)     blank control blank sample OD OD OD OD ty Cytotoxici    /   (4)  Toxins 2011, 3                         
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Each experiment was performed in triplicate (n = 3) and standard deviation is displayed in each 
figure. Statistical significance of the values was calculated by using the t-test method.  
3. Results and Discussion 
3.1. RTA Expression and Purification 
For recombinant ricin expression in E. coli, each RTA variant was PCR-amplified from plasmid 
pRS316K2SP-RTA [31] by adding BamHI and HindIII cleavage sites to the 5'- and 3'-end, respectively. 
The resulting BamHI/HindIII fragments were ligated into pET24a
(+) to obtain the expression vectors 
pET-RTA,  pET-RTAKDEL  and  pET-RTAKDEL  (Figure  1A).  As  His-tagged  RTA  variants  had 
already been successfully expressed in E. coli [25,32], we used similar expression conditions for our 
constructs. In sonicated supernatants of the corresponding E. coli transformants strong protein bands at 
approximately 31 kDa were detectable by Coomassie staining which nicely matched the calculated 
size of RTA (31.0 kDa), RTA
HDEL (31.5 kDa) and RTA
KDEL (31.5 kDa) (Figure 1B). As expected, no 
RTA signal was detectable in the vector control and in cells cultivated under non-inducing conditions 
(data not shown). To concentrate and purify the protein after Ni
2+-NTA affinity chromatography, each 
column fraction was analyzed by SDS-PAGE and Coomassie staining or western analysis probed with 
anti-RTA. Based on total protein content, all RTA variants were judged to be 90–95% pure with an 
overall yield of 40–50 mg/L RTA (Figure 1B). 
Figure 1. (A) Schematic outline of ricin toxin A (RTA) variants used in this study. In each 
fusion  protein,  the  type  of  endoplasmic  reticulum  (ER)  retention  signal  fused  to  RTA 
(K/HDEL)  and  the  total  size  (in  bp)  is  indicated.  Length  of  the  (His)6-tag  and  the 
mammalian-  or  yeast-specific  ER  retention  motifs  are  also  shown.  RTA  fusions  were 
cloned  into  pET24a
(+)  and  expressed  in  E.  coli;  (B)  RTA  purification  by  Ni
2+-NTA 
chromatography.  Purified  samples  (15-25  µg)  were  analyzed  by  SDS-PAGE  and 
Coomassie  staining.  Lane  1:  PAGE  Ruler  prestained  (Fermentas);  Lane  2:  unmodified 
RTA; Lane 3: RTA
HDEL; Lane 4: RTA
KDEL. 
(A)  (B) 
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3.2. RTA Containing a Mammalian or Yeast Specific ER Retention Signal is in vivo Toxic 
To confirm that RTA variants expressed in E. coli are biologically active against mammalian cells, 
XTT cell viability assays were performed in which mitochondrial dehydrogenase activity of HeLa S3 
cells was measured as an indirect means of cell viability. To ensure that the cells are not negatively 
affected by endogenous E. coli proteins, a negative control was included corresponding to NTA-purified 
proteins from E. coli clones expressing the empty vector. As shown in Figure 2A, no toxic effect was 
detectable in either untreated or negative control samples, whereas cell viability significantly declined 
24 h after treatment with either RTA
KDEL or RTA
HDEL (data not shown); after toxin treatment for 48 h, 
loss in cell viability further increased to 71.4% for RTA
KDEL and 68% for RTA
HDEL (Figure 2A), 
thereby confirming previous reports on RTA
KDEL toxicity against mammalian cell lines such as HeLa, 
MCF, Jurkart and Vero [26,32]. Unexpectedly however, we did not observe any significant decrease in 
cell  viability  after  treatment  with  unmodified  RTA  at  or  below  concentrations  of  12  µg  RTA  
(Figure 2A; data  at  lower toxin  concentrations  are not shown).  The  fact  that unmodified RTA is  
non-toxic on mammalian cells confirms recent data of Wang and colleagues [33]. In contrast, in vitro 
protein inhibition studies of Wales et al. demonstrated that unmodified RTA is active at high toxin 
concentration, however its inhibitory potential against HeLa cells was up to 10-fold lower compared to 
RTA
KDEL [25]. Our present study confirms these data as we also observe significant in vivo toxicity of 
non-modified RTA at toxin concentrations >80 µg after 48 h (data not shown). We thus assume that 
cells treated with low doses of RTA are being inhibited in protein biosynthesis; however this inhibition 
is not sufficient to induce in vivo cell death. This might explain the observed lack in RTA toxicity 
under low toxin concentrations in XTT viability assays. To our knowledge, we showed here for the 
first  time  that  the  addition  of  a  yeast  specific  ER  retention  signal  (HDEL)  to  RTA  results  in  a 
comparably  strong  cytotoxic  effect  to  what  can  be  observed  for  RTA
KDEL  on  HeLa  cells.  Dose 
response curves and p-value calculations of both constructs did not show any significant difference in 
the  presence  of  0.1  to  80  µg  toxin  (data  not  shown).  One  possible  explanation  for  the  increased 
cytotoxicity of RTA
HDEL could be that mammalian cells—in contrast to yeast—possess three different 
ER retention signal recognizing KDEL receptors. One of them (Erd23) has been shown to recognize 
HDEL carrying proteins and to catalyze subsequent retrograde transport back to the ER [34]; in this 
study it was demonstrated that Erd21 preferentially recognizes KDEL, whereas Erd23 mainly binds 
proteins  with  a  C-terminal  HDEL  motif;  our  present  cell  viability  data  are  consistent  with  these 
findings. To fortify the cell viability data, we looked at the morphology of HeLa cells before and after 
RTA treatment (Figure 2C). Negative control cells did not show any visible change in morphology 
compared to untreated or buffer treated cells (data not shown). The majority of cells grew adherent on 
the bottom of the well and showed normal growth behavior; only a minimal amount of detached cells 
was detectable. Samples treated with unmodified RTA showed the same unchanged phenotype as 
negative  control  cells  (Figure  2C);  this  result was  also  confirmed  by  the  numbers  of  trypan  blue 
positive cells which likewise was not altered in RTA-treated cells (Figure 2B). In contrast, HeLa cells 
treated with either RTA
HDEL or RTA
KDEL showed significant higher numbers of detached cells at 24 h, 
while after 48 h most of the cells grew non-adherent and were detached from the bottom of the well 
(Figure 2C). Moreover, trypan blue staining of cells treated with RTA
HDEL or RTA
KDEL identified a 
high number of dead cells compared to negative control cells or cells treated with unmodified RTA Toxins 2011, 3                         
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(Figure 2B). In these samples, cell numbers were reduced over 50% compared to RTA lacking an ER 
retention motif (data not shown). So, in total, our data from cell viability assays, trypan blue staining 
and phase contrast microscopy altogether demonstrate that the addition of both, HDEL or KDEL to 
RTA results in a significant increase in the in vivo toxicity against HeLa cells.  
Figure 2. RTA containing a mammalian- or yeast-specific ER retention signal is toxic to 
HeLa cells. (A) XTT based cell viability assay of HeLa cells. Cells were incubated in the 
presence of 12 µg of the indicated RTA variant and controls for 48 h (buffer control set to 
100%).  Each  experiment  was  performed  in  triplicate  (n  =  3)  and  standard  deviation 
(red bar) and p-values (* p < 0.05) are indicated; (B) Trypan blue staining of HeLa cells 
treated with 12 µg of each toxin variant after an incubation of 24 (black) or 48 (white) 
hours. Schemata show HeLa cell viability in % and the standard deviation for each sample 
(red  bar).  Each  measurement  was  performed  twice  (n = 2).  For  p-value  calculation,  
RTA-treated samples  were compared to  the negative control (* p < 0.05;  ** p < 0.01);  
(C)  Phase  contrast  microscopy  of  RTA  treated  HeLa  cells  after  48 h  (10,000 
magnification).  Cells  were  incubated  in  the  presence  of  12  µg  of  the  indicated  RTA  
protein fusion.  
 
3.3. Recombinant RTA Variants Induce Cell Death in Yeast Spheroplasts 
In further experiments we wanted to analyze whether or not RTA, RTA
HDEL and/or RTA
KDEL also 
influence cell viability in yeast. Since yeast cells do not possess terminal galactose residues within 
their cell wall components, native ricin cannot enter yeast cells because potential RTB binding sites are 
lacking on the yeast cell surface [15]. Therefore, all studies on intracellular RTA transport in yeast had Toxins 2011, 3                         
 
842 
so  far  been  restricted  to  the  analysis  of  toxin  retrotranslocation  from  the  ER  into  the  cytosol  by 
expressing RTA variants in the ER [16,24,31]. Because of this restriction in using yeast as model to 
study toxin uptake and trafficking, we aimed to establish a modified yeast system by-passing these 
limitations. Such a system would have a big advantage over mammalian cells as an entire collection of 
yeast knock-out mutants is available allowing a comprehensive genetic screening to identify genes 
whose products are directly or indirectly involved in intracellular RTA transport. Potential candidates 
identified in yeast can then be analyzed for their particular function in mammalian cells. With such an 
assay, we could look at the ER upstream transport of RTA from the cell membrane to the ER. To 
bypass the lack of ricin binding sites in the cell wall of yeast, we generated yeast spheroplasts by 
zymolyase treatment and subsequently performed oxygen sensor microtiter plate assays to analyze 
yeast  sensitivity  against  RTA  [30].  If  RTA  was  toxic  for  yeast  spheroplasts,  dissolved  oyxgen 
concentration would be expected to stay constant. As illustrated in Figure 3A, we indeed observed 
such an effect in spheroplasts, while intact yeast cells showed the expected rapid decrease in dissolved 
oxygen,  corresponding  to  the  effect  seen  in  the  negative  controls.  The  experiments  with  yeast 
spheroplasts  uncovered  an  additional  important  finding:  RTA,  RTA
HDEL  and  RTA
KDEL  likewise 
showed similar constant and high levels in dissolved oxygen at concentrations of about 12–50 µg RTA 
(Figure 3B), while the negative control sample showed a similar kinetic in oyxgen consumption as 
untreated spheroplasts. Compared to intact cells, yeast spheroplasts showed slower oxygen uptake over 
time, resulting in a shift seen in the time course (Figure 3B) which is likely caused by a slower growth 
of yeast spheroplasts which hardly double during the time course of the experiment. Nevertheless our 
data support the hypothesis that RTA is taken up by yeast spheroplasts and finally reaches the cytosol 
to inhibit protein biosynthesis.  In contrast, the cell wall of intact  yeast prevents toxin uptake and 
therefore causes RTA resistance. The current data also shows that RTA lacking a C-terminal retention 
signal is biologically active against yeast spheroplasts, while it completely loses its in vivo toxicity 
after heat-treatment at 95 ° C for 20 min (Figure 3D). As no significant difference in dissolved oxygen 
concentration was seen against the three tested RTA variants at high toxin concentration, we analyzed 
RTA toxicity on yeast spheroplasts at low toxin concentration. As illustrated in Figure 3B, RTA
HDEL 
resulted in a mean average of 79.8% dissolved oxygen after 16 h which was significantly higher than 
dissolved oxygen concentrations present in samples that had been treated with either RTA (47.1%) or 
RTA
KDEL  (50.5%);  both  variants—RTA  and  RTA
KDEL—showed  similar  kinetics  at  a  low  toxin 
concentration  of  3  µg  (Figure  3C).  p-values  below  0.05  and  0.01  confirmed  significance  of  the 
observed effect in comparison to RTA
HDEL (data not shown). Taken together, these results indicate that 
the yeast-specific ER retention motif HDEL is more efficient in ensuring retrograde RTA transport than the 
mammalian-specific retention signal KDEL. This might be explained by the fact that yeast—in contrast 
to mammals—only possess a single cellular HDEL receptor (Erd2p) which preferentially recognizes 
and binds HDEL-carrying proteins within the secretory pathway [35,36]. 
3.4. RTA Endocytosis is an Essential Prerequisite for Cell Killing 
Since endocytotic uptake of only a limited number of toxin molecules is sufficient for in vivo cell 
killing [37], we asked if spheroplasts of a yeast Δend3 mutant which is blocked in early steps of both, 
fluid-phase and receptor endocytosis [38] behave phenotypically RTA resistant when tested under the Toxins 2011, 3                         
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same conditions as wild-type cells. As illustrated in Figure 3F, this was indeed the case and Δend3 
cells were effectively protected against all three toxin variants RTA, RTA
KDEL and RTA
HDEL. The 
same resistant phenotype was also seen in spheroplasts of a Δrpl12B mutant (Figure 3E) which expresses 
a mutant ribosomal protein of the 60S subunit that prevents ricin-mediated 28S rRNA depurination within 
the sarcin/ricin loop [39]. 
Figure 3. RTA toxicity against yeast spheroplasts. Dissolved oxygen concentration was 
measured for intact wild-type cells (WT) and spheroplasts in the presence of the indicated 
RTA variant. All experiments were performed in triplicate (n = 3) at 30 ° C and 120 rpm 
over 16 h. (A) Intact wild-type yeast cells treated with 50 µg of the indicated RTA variant; 
(B,C) Same experiment performed on yeast spheroplasts in the presence of 50 or 3 µg 
RTA;  (D)  Spheroplasts  treated  with  50  µg  RTA  before  and  after  heat-inactivation;  
(E,F) Yeast spheroplasts of a Δrpl12B or Δend3 mutant in the presence of 50 µg of the 
indicated RTA variant. 
 
To further confirm the power and significance of the yeast-based RTA toxicity assay described here, 
we  additionally  performed  propidium-iodide  (PI)  staining  of  yeast  spheroplasts  and  determined  PI 
fluorescence  intensity  after  RTA  treatment.  As  summarized  in  Figure  4,  a  significant  increase  in 
fluorescence was only seen in yeast spheroplasts (and not in whole cells) after RTA treatment at high Toxins 2011, 3                         
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toxin concentration (12 µg), thereby nicely confirming our previous results from oxygen consumption 
measurements (see Figure 3B).  
Figure 4. PI fluorescence of RTA-treated intact cells and yeast spheroplasts. Propidium 
iodide (PI) fluorescence intensity of yeast spheroplasts and intact cells after treatment with 
the indicated RTA variant. In the positive control (set to 100%), cells were heat-inactivated 
at 95 ° C for 20 min. In each case, cells were incubated in the presence of 12 µg of the 
indicated RTA variant for 24 h (mean average of five independent experiments; standard 
deviation (red bar) and p-values (* p < 0.05, ** p < 0.01) are indicated). 
 
4. Conclusions 
In the present study we demonstrate that both the addition of a mammalian- and/or a yeast-specific 
ER  retention  signal  (HDEL,  KDEL)  to  the  C-terminus  of  RTA  significantly  increases  its  in  vivo 
toxicity against mammalian cells and yeast cell spheroplasts. Furthermore, we established an oxygen 
sensor based bioassay which now opens the possibility to use yeast as model to study A/B toxin uptake 
and intracellular trafficking in more detail. We believe that this bioassay will be helpful to dissect and 
mechanistically  understand  how  microbial,  plant  and  viral  A/B  toxins  can  efficiently  intoxicate 
mammalian  cells.  Such  comprehensive  screening  in  yeast  might  also  bring  up  novel  targets  and 
therapeutic strategies for the treatment of various human diseases, including cancer. 
Acknowlegments 
We  are  grateful  to  Lynne  Roberts  for  kindly  providing  the  ricin  A  antibody  and  the  plasmid 
pRS316-K2SP-RTA. Special thanks to Klaus Witte for technical assistance in the affinity purification 
of recombinant RTA variants, and to the members of the Schmitt lab for helpful discussions, especially 
to Nina Mü ller, Thorsten Hoffmann, Esther Gieß elmann, Bjö rn Diehl and Frank Breinig. BB was 
kindly supported by a PhD fellowship from Saarland University. This study was in part supported by a 
grant from the Deutsche Forschungsgemeinschaft to MJS. Toxins 2011, 3                         
 
845 
References 
1.  Montanaro, L.; Sperti, S.; Stirpe, F. Inhibition by ricin of protein synthesis in vitro. Ribosomes as 
the target of the toxin. Biochem. J. 1973, 136, 677–683. 
2.  Day, P.J.; Owens, S.R.; Wesche, J.; Olsnes, S.; Roberts, L.M.; Lord, J.M. An interaction between 
ricin and calreticulin that may have implications for toxin trafficking. J. Biol. Chem. 2001, 276, 
7202–7208. 
3.  Weston, S.A.; Tucker, A.D.; Thatcher, D.R.; Derbyshire, D.J.; Pauptit, R.A. X-ray structure of 
recombinant ricin A-chain at 1.8 A resolution. J. Mol. Biol. 1994, 244, 410–422. 
4.  Endo, Y.; Tsurugi, K. RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the 
toxic lectin ricin on eukaryotic ribosomes. J. Biol. Chem. 1987, 262, 8128-8130. 
5.  Szewczak, A.A.; Moore, P.B.; Chang, Y.L.; Wool, I.G. The conformation of the sarcin/ricin loop 
from 28S ribosomal RNA. Proc. Natl. Acad. Sci. USA 1993, 90, 9581-9585. 
6.  Moazed, D.; Robertson, J.M.; Noller, H.F. Interaction of elongation factors EF-G and EF-Tu with 
a conserved loop in 23S RNA. Nature 1988, 334, 362–364. 
7.  Newton,  D.L.;  Wales,  R.;  Richardson,  P.T.;  Walbridge,  S.;  Saxena,  S.K.;  Ackerman,  E.J.;  
Roberts, L.M.; Lord, J.M.; Youle, R.J. Cell surface and intracellular functions for ricin galactose 
binding. J. Biol. Chem. 1992, 267, 11917–11922. 
8.  Sandvig, K.; Olsnes, S. Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin 
into  cells.  II.  Effect  of  pH,  metabolic  inhibitors,  and  ionophores  and  evidence  for  toxin 
penetration from endocytotic vesicles. J. Biol. Chem. 1982, 257, 7504–7513. 
9.  Moya,  M.;  Dautry-Varsat,  A.;  Goud,  B.;  Louvard,  D.;  Boquet,  P.  Inhibition  of  coated  pit 
formation in Hep2 cells blocks the cytotoxicity of diphtheria toxin but not that of ricin toxin.  
J. Cell Biol. 1985, 101, 548–559. 
10.  Iversen, T.G.; Skretting, G.; Llorente, A.; Nicoziani, P.; van Deurs, B.; Sandvig, K. Endosome to 
Golgi transport of ricin is independent of clathrin and of the Rab9- and Rab11-GTPases. Mol. 
Biol. Cell 2001, 12, 2099–2107. 
11.  Sandvig, K.; van Deurs, B. Endocytosis, intracellular transport, and cytotoxic action of Shiga 
toxin and ricin. Physiol. Rev. 1996, 76, 949–966. 
12.  van Deurs, B.; Sandvig, K.; Petersen, O.W.; Olsnes, S.; Simons, K.; Griffiths, G. Estimation of 
the  amount  of  internalized  ricin  that  reaches  the  trans-Golgi  network.  J.  Cell  Biol.  1988,  106,  
253–267. 
13.  Stechmann, B.; Bai, S.K.; Gobbo, E.; Lopez, R.; Merer, G.; Pinchard, S.; Panigai, L.; Tenza, D.; 
Raposo, G.; Beaumelle, B.; et al. Inhibition of retrograde transport protects mice from lethal ricin 
challenge. Cell 2010, 141, 231–242. 
14.  Lord,  J.M.;  Roberts,  L.M.;  Lencer,  W.I.  Entry  of  protein  toxins  into  mammalian  cells  by 
crossing the endoplasmic reticulum membrane: Co-opting basic mechanisms of endoplasmic 
reticulum-associated degradation. Curr. Top. Microbiol. Immunol. 2005, 300, 149–168. 
15.  Lord, J.M.; Roberts, L.M.; Robertus, J.D. Ricin: Structure, mode of action, and some current 
applications. FASEB J. 1994, 8, 201–208. Toxins 2011, 3                         
 
846 
16.  Simpson, J.C.; Roberts, L.M.; Romisch, K.; Davey, J.; Wolf, D.H.; Lord, J.M. Ricin A chain 
utilises the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of 
yeast. FEBS Lett. 1999, 459, 80–84. 
17.  Sokolowska, I.; Walchli, S.; Wegrzyn, G.; Sandvig, K.; Slominska-Wojewodzka, M. A single 
point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER 
retrotranslocation. Biochem. J. 2011, 2, 371–385. 
18.  Slominska-Wojewodzka,  M.;  Gregers,  T.F.;  Walchli,  S.;  Sandvig,  K.  EDEM  is  involved  in 
retrotranslocation of ricin from the endoplasmic reticulum to the cytosol. Mol. Biol. Cell 2006, 17, 
1664–1675. 
19.  Lord, M.J.; Jolliffe, N.A.; Marsden, C.J.; Pateman, C.S.; Smith, D.C.; Spooner, R.A.; Watson, P.D.; 
Roberts, L.M. Ricin. Mechanisms of cytotoxicity. Toxicol. Rev. 2003, 22, 53–64. 
20.  Zhou, X.X.; Ji, F.; Zhao, J.L.; Cheng, L.F.; Xu, C.F. Anti-cancer activity of anti-p185HER-2 ricin A 
chain immunotoxin on gastric cancer cells. J. Gastroenterol. Hepatol. 2010, 25, 1266–1275. 
21.  Surash,  S.;  Nemeth,  P.;  Chakrabarty,  A.;  Chumas,  P.  The  conjugation  of  an  AQP1-directed 
immunotoxin in the study of site-directed therapy within the CNS. Childs Nerv. Syst. 2011, 27, 
811–818. 
22.  Mathew, M.; Verma, R.S. Humanized immunotoxins: A new generation of immunotoxins for 
targeted cancer therapy. Cancer Sci. 2009, 100, 1359–1365. 
23.  Bradley,  J.L.;  Silva,  H.M.;  McGuire,  P.M.  Depurination  of  yeast  26S  ribosomal  RNA  by 
recombinant ricin A chain. Biochem. Biophys. Res. Commun. 1987, 149, 588–593. 
24.  Li,  S.;  Spooner,  R.A.;  Allen,  S.C.;  Guise,  C.P.;  Ladds,  G.;  Schnoder,  T.;  Schmitt,  M.J.;  
Lord, J.M.; Roberts, L.M. Folding-competent and folding-defective forms of ricin A chain have 
different fates after retrotranslocation from the endoplasmic reticulum. Mol. Biol. Cell 2010, 21, 
2543–2554. 
25.  Wales, R.; Roberts, L.M.; Lord, J.M. Addition of an endoplasmic reticulum retrieval sequence to 
ricin A chain significantly increases its cytotoxicity to mammalian cells. J. Biol. Chem. 1993, 268, 
23986–23990. 
26.  Wales, R.; Chaddock, J.A.; Roberts, L.M.; Lord, J.M. Addition of an ER retention signal to the 
ricin A chain increases the cytotoxicity of the holotoxin. Exp. Cell Res. 1992, 203, 1–4. 
27.  Sambrook, J.; Maniatis, T.; Fritsch, E.F. Molecular Cloning: A Laboratory Manual; 2nd ed.; Cold 
Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 1989. 
28.  Schagger, H.; von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 1987, 166, 368–379. 
29.  Schagger, H.; Aquila, H.; von Jagow, G. Coomassie blue-sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis for direct visualization of polypeptides during electrophoresis. Anal. Biochem. 
1988, 173, 201–205. 
30.  John, G.T.; Klimant, I.; Wittmann, C.; Heinzle, E. Integrated optical sensing of dissolved oxygen 
in  microtiter  plates:  A  novel  tool  for  microbial  cultivation.  Biotechnol.  Bioeng.  2003,  81,  
829–836. 
31.  Allen,  S.C.;  Moore,  K.A.;  Marsden,  C.J.;  Fulop,  V.;  Moffat,  K.G.;  Lord,  J.M.;  Ladds,  G.; 
Roberts,  L.M.  The  isolation  and  characterization  of  temperature-dependent  ricin  A  chain 
molecules in Saccharomyces cerevisiae. FEBS J. 2007, 274, 5586–5599. Toxins 2011, 3                         
 
847 
32.  Zhan, J.; de Sousa, M.; Chaddock, J.A.; Roberts, L.M.; Lord, J.M. Restoration of lectin activity to 
a  non-glycosylated  ricin  B  chain  mutant  by  the  introduction  of  a  novel  N-glycosylation  site.  
FEBS Lett. 1997, 407, 271–274. 
33.  Wang, M.; Yu, S.; Wang, C.; Kong, J. Tracking the endocytic pathway of recombinant protein 
toxin delivered by multiwalled carbon nanotubes. ACS Nano 2010, 4, 6483–6490. 
34.  Raykhel, I.; Alanen, H.; Salo, K.; Jurvansuu, J.; Nguyen, V.D.; Latva-Ranta, M.; Ruddock, L.  
A molecular specificity code for the three mammalian KDEL receptors. J. Cell Biol. 2007, 179, 
1193–1204. 
35.  Semenza, J.C.; Hardwick, K.G.; Dean, N.; Pelham, H.R. ERD2, a yeast gene required for the 
receptor-mediated retrieval of luminal ER proteins from the secretory pathway. Cell 1990, 61, 
1349–1357. 
36.  Semenza,  J.C.;  Pelham,  H.R.  Changing  the  specificity  of  the  sorting  receptor  for  luminal 
endoplasmic reticulum proteins. J. Mol. Biol. 1992, 224, 1–5. 
37.  Eiklid, K.; Olsnes, S.; Pihl, A. Entry of lethal doses of abrin, ricin and modeccin into the cytosol 
of HeLa cells. Exp. Cell Res. 1980, 126, 321–326. 
38.  Raths,  S.;  Rohrer,  J.;  Crausaz,  F.;  Riezman,  H.  end3  and  end4:  two  mutants  defective  in 
receptor-mediated and fluid-phase endocytosis in Saccharomyces cerevisiae. J. Cell Biol. 1993, 
120, 55–65. 
39.  Chiou, J.C.; Li, X.P.; Remacha, M.; Ballesta, J.P.; Tumer, N.E. The ribosomal stalk is required 
for  ribosome  binding,  depurination  of  the  rRNA  and  cytotoxicity  of  ricin  A  chain  in 
Saccharomyces cerevisiae. Mol. Microbiol. 2008, 70, 1441–1452. 
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This  article is  an open  access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/) 